Healthcare Realty Trust Inc
For the period ended Jul 30, 2026. Filed Jul 30, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 30, 2026 · Filed Jul 30, 2026
Use the contents to explore the available documents and sections.
HR$19.20+0.7%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · FFO, Normalized FFO, & FAD
FFO, Normalized FFO, & FAD
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA
| SECOND QUARTER ENDED · YEAR TO DATE · FULL YEAR | |||||
|---|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | 2025 | |
| Net loss attributable to common stockholders | $(43,514) | $(157,851) | $(43,570) | $(202,724) | $(246,071) |
| Net loss attributable to common stockholders per diluted share | $(0.13) | $(0.45) | $(0.13) | $(0.58) | $(0.71) |
| Gain on sales of real estate assets | (3,713) | (20,004) | (14,490) | (22,907) | (235,389) |
| Impairments of real estate assets | 42,741 | 140,877 | 42,757 | 151,022 | 361,090 |
| Real estate depreciation and amortization | 126,955 | 152,936 | 254,876 | 308,224 | 586,146 |
| Non-controlling loss from operating partnership units | (537) | (2,293) | (547) | (2,892) | (3,497) |
| Unconsolidated JV depreciation, amortization, gain and impairment | 4,210 | 6,706 | 10,814 | 13,422 | 27,769 |
| NAREIT FFO | $126,142 | $120,371 | $249,840 | $244,145 | $490,048 |
| NAREIT FFO per common share - diluted | $0.36 | $0.34 | $0.71 | $0.69 | $1.38 |
| Transaction costs | 1,473 | 593 | 2,410 | 1,604 | 2,029 |
| Debt financing costs | 1,776 | — | 1,892 | — | 5,107 |
| Restructuring and severance-related charges | 3,021 | 10,302 | 10,583 | 10,804 | 26,318 |
| Merger-related fair value adjustment | 10,154 | 10,580 | 21,145 | 21,025 | 42,593 |
| Other | 1,137 | 1,890 | 2,215 | 3,880 | 2,851 |
| Normalized FFO | $143,703 | $143,736 | $288,085 | $281,458 | $568,946 |
| Normalized FFO per common share - diluted | $0.41 | $0.41 | $0.82 | $0.80 | $1.61 |
| Non-real estate depreciation and amortization | 789 | 1,184 | 1,452 | 2,452 | 6,114 |
| Non-cash interest amortization, net | 1,380 | 1,130 | 2,747 | 2,348 | 5,126 |
| Straight-line amortization, net | (13,716) | (8,022) | (24,007) | (15,913) | (29,392) |
| Stock-based compensation | 4,420 | 3,887 | 8,348 | 6,915 | 13,609 |
| Unconsolidated JV non-cash items | (164) | (356) | (254) | (609) | (1,420) |
| Other | — | 130 | — | 224 | 952 |
| Maintenance capex | (27,052) | (26,335) | (54,153) | $(59,301) | (115,633) |
| FAD | $109,360 | $115,354 | $222,218 | $217,574 | $448,302 |
| Quarterly dividends and OP distributions | $83,354 | $110,486 | $168,168 | $220,326 | $391,368 |
| FFO wtd avg common shares outstanding - diluted 1 | 347,161 | 354,078 | 349,672 | 353,814 | 354,454 |
1 The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstandingof 613,021 for the three months ended June 30, 2026. Also includes the diluted impact of 4,247,299 OP units outstanding.
| HEALTHCARE REALTY | Return to Table of Contents | 2Q 2026 SUPPLEMENTAL INFORMATION 9 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.